RecruitingNCT05822193

Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil


Sponsor

Inova Medical

Enrollment

1,694 participants

Start Date

Jul 21, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age ≥ 18 years;
  • Brazilian resident;
  • Symptomatica COVID-19 confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least 90 days before recruitment.

Exclusion Criteria3

  • No availability to participate in remote research appointments;
  • Communication difficulty (aphasia, important hearing loss, non-portuguese speaker, severe dementia)
  • Refuse to provide informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMultiple exposures

Exposures variables (observational study): age, gender, education, comorbidities, vaccination status, severity of the acute episode of COVID-19, treatments used for acute COVID-19.


Locations(1)

Inova Medical

Cachoeirinha, Rio Grande do Sul, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05822193


Related Trials